Cyclophosphamide Capsule
Product Images NDC 69097-517

3 FDA label images from Cipla Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cyclophosphamide (NDC 69097-517). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (F57dbebf F145 4e3c Bfef B7907f6e01eb 01)

Image (F57dbebf F145 4e3c Bfef B7907f6e01eb 01)
Chemical structure of Cyclophosphamide monohydrate, showing a phosphoramide mustard derivative with an oxazaphosphorine ring and two chloroethylamine side chains, including a water molecule (H2O).*
FDA Label Image

25mg (Cyclocapsule)

25mg (Cyclocapsule)
Packaging label for Cyclophosphamide capsules, USP 25 mg, an oral prescription drug by Cipla USA Inc. The label indicates 100 capsules per container and warns to wear gloves when handling. It notes the dosage form as capsules and classifies the drug as a cytotoxic agent. Storage and handling instructions are included, along with a barcode and regulatory information.*
FDA Label Image

50 mg (Cyclo)

50 mg (Cyclo)
Cyclophosphamide Capsules USP 50 mg oral capsules packaging label by Cipla USA Inc. The label highlights the cytotoxic nature of the agent and contains 100 capsules per package. It includes handling precautions and storage instructions, along with manufacturer details Cipla Ltd. in India and Cipla USA, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.